PMVP — Pmv Pharmaceuticals Share News
0.000.00%
Brief: Pmv Pharmaceuticals Inc Reports Q2 Net Loss of $21.2 Million
PMV Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
PMV Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: PMV Pharmaceuticals Q1 EPS USD -0.34
PMV Pharmaceuticals Inc expected to post a loss of 37 cents a share - Earnings Preview
Macquarie slashes PT on Australia's Premier Investments; shares drop
PMV Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
PMV Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Australia's Premier Investments gains; MS positive on growth prospects
Brief: Pmv Pharmaceuticals Inc Files For Mixed Shelf Of Up To $200 Million
PMV Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary
PMV Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview
Citi sees lack of immediate upside catalyst for Premier after Myer deal
Brief: Pmv Pharmaceuticals Provides A Progress Update On Pynnacle Clinical Trial
Premier Investments top loser on ASX 200 as FY profit falls, Smiggle demerger postponed
PMV Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
PMV Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview
PMV Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
PMV Pharmaceuticals Inc expected to post a loss of 36 cents a share - Earnings Preview